Larvol Delta - RealWorld-Patient-Characteristics-General-Safety-Profile-and-Treatment-Patterns-of-Elranatamab-ELRA-Use-in-Relapsed-Refractory-Multiple-Myeloma-RRMM-Interim-Results-of-the-Ambrela-Study

Elrexfio (elranatamab-bcmm) - Pfizer

https://imsannual2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=TU1XRFNPTlIyMjY0Nw&PosterID=826822&rnd=0.4618744

Thomas Chalopin, MD

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next